Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival. [electronic resource]
Producer: 20210423Description: 2010-2018 p. digitalISSN:- 2045-7634
- Adult
- Aged
- Biomarkers, Tumor -- blood
- CA-19-9 Antigen -- blood
- Carcinoembryonic Antigen -- blood
- Case-Control Studies
- Colorectal Neoplasms -- blood
- Female
- Follow-Up Studies
- Healthy Volunteers
- Humans
- Kaplan-Meier Estimate
- Male
- Mass Screening -- methods
- Middle Aged
- Midkine -- blood
- Preoperative Period
- Prognosis
- Prospective Studies
- ROC Curve
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.